{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:02:05Z","timestamp":1777543325853,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1978,1,1]],"date-time":"1978-01-01T00:00:00Z","timestamp":252460800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1978,1]]},"DOI":"10.1007\/bf03346770","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T17:19:15Z","timestamp":1395940755000},"page":"47-58","source":"Crossref","is-referenced-by-count":55,"title":["Treatment of patients with prolactinomas"],"prefix":"10.1007","volume":"1","author":[{"given":"K.","family":"von Werder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Fahlbusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Landgraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. R.","family":"Pickardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. K.","family":"Rjosk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. C.","family":"Scriba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"key":"BF03346770_CR1","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.68.8.1902","volume":"68","author":"P Hwang","year":"1971","unstructured":"Hwang P., Guyda H., Friesen H. A radioimmunoassay for human prolactin. Proc. Nal. Acad. Sci. USA 68: 1902, 1971.","journal-title":"Proc. Nal. Acad. Sci. USA"},{"key":"BF03346770_CR2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1210\/jcem-36-3-509","volume":"36","author":"YN Sinha","year":"1973","unstructured":"Sinha Y.N., Selby F.W., Lewis U.J., Vanderlaan W.P. A homologous radioimunoassay for human prolactin. J. Clin. Endocrinol. Metab. 36: 509, 1973.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03346770_CR3","volume-title":"Wachstumshormone und Prolaktinsekretion des Menschen","author":"K Werder von","year":"1975","unstructured":"von Werder K. Wachstumshormone und Prolaktinsekretion des Menschen. Urban & Schwarzenberg, Munchen-Berlin-Wien, 1975."},{"key":"BF03346770_CR4","first-page":"575","volume":"36","author":"HK Rjosk","year":"1976","unstructured":"Rjosk H.K., von Werder K, Fahlbusch R. Hyperprolaktinamische Amenorrhoe. Klinische Bedeutung, endokrine Befunde, Therapie. Geburtshilfe Frauenheilkd. 36: 575, 1976.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"BF03346770_CR5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/bmj.2.5916.419","volume":"2","author":"MO Thorner","year":"1974","unstructured":"Thorner M.O., McNeilly A.S., Hagan C., Besser G.M. Long-term treatment of galactorrhea and hypogo nadism with bromocriptine. Br. Med. J. 2: 419, 1974.","journal-title":"Br. Med. J."},{"key":"BF03346770_CR6","volume-title":"Treatment of pituitary adenomas","author":"R Fahlbusch","year":"1978","unstructured":"Fahlbusch R., Rjosk H.K., von Werder K. Operative treatment of prolactin producing adenomas. In: Fahlbusch R., Werder K.v. (Eds.), Treatment of pituitary adenomas. Thieme Verlag Stuttgart 1978, in pre"},{"key":"BF03346770_CR7","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0140-6736(77)92959-2","volume":"1","author":"S Franks","year":"1977","unstructured":"Franks S., Nabarro J.D.N., Jacobs J.S. Prevalence and presentation of hyperprolactinemia in patients with \u201cfunctionless\u201d pituitary tumors. Lancet 1: 778, 1977.","journal-title":"Lancet"},{"key":"BF03346770_CR8","first-page":"1904","volume":"82","author":"K Werder von","year":"1976","unstructured":"von Werder K., Fahlbusch R., Landgraf R., Pickardt C.R., Rjosk H.K., Scriba P.C. Operative und medikamentbse Behandlung von Pro-laktin produzierenden Hypophysentumoren. Verh. Dtsch. Ges. Inn. Med. 82: 1904, 1976.","journal-title":"Verh. Dtsch. Ges. Inn. Med."},{"key":"BF03346770_CR9","volume-title":"Human Prolactin Excerpta Medica, Amsterdam","author":"PM Cotes","year":"1973","unstructured":"Cotes P.M. Research standard A for human prolactin (in ampoules codes 71 \/222). In: Pasteels J.L., Robyn C. (Eds.), Human Prolactin Excerpta Medica, Amsterdam, 1973."},{"key":"BF03346770_CR10","first-page":"358","volume":"96","author":"K Werder von","year":"1975","unstructured":"von Werder K., Clemm C., Kerner W., Scriba P.C. A hPRL-RIA using antibodies against the \u00ablittle\u00bb component of serum-hPRL. Endocrinology 96: 358, 1975, Abstract.","journal-title":"Endocrinology"},{"key":"BF03346770_CR11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2265.1977.tb03342.x","volume":"6","author":"G Tolis","year":"1977","unstructured":"Tolis G. Galactorrhea-amenorrhea and hyperprolactinemia: Pathophysiological aspects and diagnostic tests. Clin. Endocrinol. (Oxf) 6: 81, 1977.","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"BF03346770_CR12","first-page":"46","volume":"208","author":"R Fahlbusch","year":"1977","unstructured":"Fahlbusch R., Rjosk H.K., von Werder K. Perioperative prolactin levels in patients with prolactinomas. Acta Endocrinol. (Suppl) (Kbh) 208: 46, 1977.","journal-title":"Acta Endocrinol. (Suppl) (Kbh)"},{"key":"BF03346770_CR13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2265.1972.tb00401.x","volume":"1","author":"IA Forsyth","year":"1972","unstructured":"Forsyth I.A., Edwards C.R.W. Human prolactin: Its isolation, assay and clinical applications. Clin. Endocrinol. (Oxf) 1: 293, 1972.","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"BF03346770_CR14","first-page":"847","volume":"103","author":"E Pozo Del","year":"1973","unstructured":"Del Pozo E., Friesen H., Burmeister P. Endocrine profile of a specific prolactin inhibitor: Brergocryptine (CB-154). Schweiz. Med. Wochenschr. 103: 847, 1973.","journal-title":"Schweiz. Med. Wochenschr."},{"key":"BF03346770_CR15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1210\/jcem-39-1-18","volume":"39","author":"E Pozo Del","year":"1974","unstructured":"Del Pozo E., Varga L., Wyss H., Tolis G., Friesen H., Wenner R., Vetter L. Uettwiler A. Clinical and hormonal response to bromocriptin (CB-154) in the galactorrhea syndromes. J. Clin. Endocrinol. Metab. 39: 18, 1974.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03346770_CR16","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1210\/jcem-35-5-768","volume":"35","author":"E Pozo Del","year":"1972","unstructured":"Del Pozo E., Brun del Re R., Varga L., Friesen H. Inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine). J. Clin. Endocrinol. Metab. 35: 768, 1972.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03346770_CR17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00745135","volume":"13","author":"R Landgraf","year":"1977","unstructured":"Landgraf R., Landgraf-Leurs M.M.C., Weissmann A., Horl R., von Werder K., Scriba P.C. Prolactin: A diabetogenic hormone. Diabetologia 13: 99, 1977.","journal-title":"Diabetologia"},{"key":"BF03346770_CR18","first-page":"169","volume-title":"Frontiers in Neuroen-docrinology","author":"AG Frantz","year":"1973","unstructured":"Frantz A.G. The regulation of prolactin secretion in humans. In: Ganong W.F., Martini L. (Eds.) Frontiers in Neuroen-docrinology. Oxford Univ. Press, London, Toronto, 1973, P. 169."},{"key":"BF03346770_CR19","volume-title":"Endocrinology","author":"GM Besser","year":"1977","unstructured":"Besser G.M., Thorner M.O., Wass J.A.H. Hyperprolactinemia-hypogonadism syndrome \u2014 medical treatment. In: V.H.T. James (Ed.), Endocrinology. Amsterdam, Oxford, Excerpta Medica, 1977."},{"key":"BF03346770_CR20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2265.1977.tb03343.x","volume":"6","author":"HG Friesen","year":"1977","unstructured":"Friesen H.G., Tolis G. The use of bromocriptine in the galactorrhea-amenhorrhea syndromes: The Canadian Cooperative Study. Clin. Endocrinol. (Oxf) 6: 91, 1977.","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"BF03346770_CR21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1210\/jcem-40-4-705","volume":"40","author":"PG Chiodini","year":"1975","unstructured":"Chiodini P.G., Liuzzi A., Botalla L., Oppizzi G., Muller E.E., Silvestrini F. Stable reduction of plasma growth hormone (hGH) levels during chronic administration of 2-bromo-alpha-ergocriptine (CB-154) in acromegalic patients. J. Clin. Endocrinol. Metab. 40: 705, 1975.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03346770_CR22","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1210\/jcem-38-5-910","volume":"38","author":"A Liuzzi","year":"1974","unstructured":"Liuzzi A., Chiodini P.G., Botalla L., Cremascoli G., Muller E.E., Silvestrini F. Decreased plasma growth hormone (GH) levels in acromegalics following CB-154 (2-Br-alpha-ergocryptine) admnistration. J. Clin. Endocrinol. Metab. 38: 910, 1974.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03346770_CR23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bmj.1.5953.299","volume":"1","author":"MO Thorner","year":"1975","unstructured":"Thorner M.O., Chait A., Aitken M., Benker G., Bloom S.R., Mortimer C.H., Sanders P., Stuart Mason A., Besser G.M. Bromocriptine treatment of acromegaly. Br. Med. J. 1: 299, 1975.","journal-title":"Br. Med. J."},{"key":"BF03346770_CR24","first-page":"1540","volume":"100","author":"J Kobberling","year":"1975","unstructured":"Kobberling, J., Schwinn G., Dirks H. Die Behandlung der Akromegalie mit Bromocriptin. Dtsch. Med. Wochenschr. 100: 1540, 1975.","journal-title":"Dtsch. Med. Wochenschr."},{"key":"BF03346770_CR25","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1530\/acta.0.0820746","volume":"82","author":"GH Daniels","year":"1976","unstructured":"Daniels G.H., Kourides I.A., Maloof F. Breast cancer in Forbes-Albright syndrome. Acta Endocrinol. (Kbh) 82: 746, 1976.","journal-title":"Acta Endocrinol. (Kbh)"},{"key":"BF03346770_CR26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1210\/jcem-43-1-137","volume":"43","author":"K Horn","year":"1976","unstructured":"Horn K., Erhardt F., Fahlbusch R., Pickardt C.R., von Werder K., Scriba P.C. Recurrent thyrotoxic goiter and galactorrhea-amenorrhea syndrome due to an autonomous thyrotropin and prolactin producing pituitary adenoma. J. Clin. Endocrinol. Metab. 43: 137, 1976.","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346770.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03346770\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:13:44Z","timestamp":1565309624000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03346770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1978,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1978,1]]}},"alternative-id":["BF03346770"],"URL":"https:\/\/doi.org\/10.1007\/bf03346770","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1978,1]]}}}